Introduction
the translation start site. The mouse MOR promoter contains a 5´-distal promoter regulatory sequence: a 34-bp cis-acting element that possesses a strong inhibitory effect against the transcriptional function of the distal promoter [13] . Both promoters exhibit characteristics of housekeeping genes lacking a TATA box. The distal promoter is known to be 20-fold less active than the proximal promoter, based on quantitative RT-PCR using adult and embryonic mouse brains [14] . The proximal promoter appears to be the predominant promoter for directing MOR gene transcription in the adult mouse brain, as well as during embryonic development [12, 14] . [15, 16] . [15, 17] . [19] [20] [21] [22] [23] [24] . Kraus et al. [25] [25] . [26] . [27] [28] [29] [30] . 
The mammalian poly(ADP-ribose) polymerase 1 (PARP-1)-the major isoform of the PARP-1 family-is comprised of 1014 amino acids (114 kD) and is expressed continuously in eukaryotes. It has a 46-kD DNA-binding domain at the N-terminal containing a DEVD sequence, which acts as a target for caspase-3 during apoptosis. When cleaved by caspase-3, PARP-1 is inactivated, resulting in the formation of two proteolytic fragments: a 29-kD amino-terminal fragment and an 85-kD carboxyl-terminal fragment. A 54-kD domain of PARP-1 located in the carboxyl terminus represents the ␤-nicotinamide adenine dinucleotide (NAD + )-binding domain

Between the DNA-binding domain and the catalytic domain is a 22-kD automodification domain that facilitates the homo/heterodimerization of PARP-1 with other proteins
PARP-1's basal enzymatic activity is very low, but is stimulated dramatically in the presence of a variety of allosteric activators, including damaged DNA [18]. The targets of PARP-1's enzymatic activity include PARP-1 itself (the primary target in vivo), core histones, the linker histone H1 and a variety of transcriptionrelated factors (e.g. p53, fos, NF-B, RNA polymerase I and II)
PARP-1 modulates gene expression in both a positive and a negative fashion, with the final effects depending on the cell type, the gene and the transcription factor involved. For example, when bound to DNA, PARP-1 impairs RNA polymerase II activity
However, conflicting results suggest that PARP-1 is localized preferentially in regions of actively transcribed chromatin and able to enhance transcription by promoting protein complex formation on the enhancer template. PARP-1 facilitates the detection of transcription initiation DNA sequences and promotes the activity of transcription factors such as activator protein 2 (AP-2), Oct-1, NF-B and p53
In this study, we report the identification and characterization of a poly(C)-sequence-binding protein that regulates mouse MOR gene regulation. We employed affinity column chromatography containing a specific competitor, two-dimensional gel electrophoresis (2-DE) and mass spectrometry to purify and identify the specific factor interacting between the poly(C) sequence of the MOR proximal promoter region and its binding proteins in mouse NS20Y neuroblastoma cells. PARP-1 was identified as a poly(C)-
Materials and Methods
Plasmid construction
Nuclear extract preparation
Nuclear extracts were prepared from NS20Y cells as described previously [33] . Briefly 
Autopoly(ADP-ribosyl)ation of PARP-1
Electrophoretic mobility shift assay (EMSA)
The EMSA was performed as described previously [36] . 
Chromatin immunoprecipitation (ChIP) assay and real-time quantitative PCR (qPCR)
Chromatin immunoprecipitation (ChIP) assays were performed by using a modified protocol from Upstate Biotechnology as previously reported [2] . 
Results
Isolation and identification of a new transcription factor that interacts with poly(C) DNA sequences in the mouse MOR proximal promoter
Studies from our laboratory have shown that expression of mouse MOR is driven by two promoters, distal and proximal [12] . [38] . The poly(C) sequence (Fig. 1A) is essential for promoter activity of the mouse MOR. We report here the discovery of another regulator for this MOR promoter through binding to the poly(C) sequence, identified using the following new procedure (Fig. 1B) (Fig. 2) , the protein was identified as PARP-1. In general, PARP-1 exists in cells in both unribosylated and ribosylated forms [40, 41] . The pI of unribosylated PARP-1 is basic (10) (11) Fig. 3A ) from the MOR poly(C) sequence as a probe. Only one major band (Fig. 3C, arrow) , indicating the PARP-1/NS complex, was detected (Fig. 3C, lane 2) . (Fig. 3C, lane 3 (Fig. 3E) . (Fig. 4B, lanes 5, 7 and 9 , respectively), although at reduced levels relative to samples without competitor (Fig. 4B, lane 1) . No PARP-1 complexes were observed when unlabelled NS was used as a competitor (Fig. 4B, lanes 2) . Reduced PARP-1 binding to labelled NS was observed using M1, M2, M4, M6 and M8 (Fig. 4B,  lanes 3, 4, 6, 8 Fig. 4C ) serve as PARP-1 binding motifs within the mouse MOR proximal promoter. (Fig. 5B) . However, PARP-1 could not repress the promoter activity (Fig. 5C (Fig. 6A) . However, RT-PCR revealed that in the presence of PARP-1 siRNA, MOR mRNA levels increased 80% relative to the controls (Fig. 6C) , while ␤-actin mRNA levels were 
Previously, we reported that MOR transcription is regulated by a cis-acting poly(C) sequence in the mouse MOR promoter through the binding of Sp1 and Sp3
and the pI of ribosylated PARP-1 is acidic. The low pI (i.e. 4) of the purified PARP-1 indicates that the poly(C)-binding form of PARP-1 is ribosylated.
PARP-1 binds specifically to poly(C) DNA sequences of the mouse MOR proximal promoter
Before performing EMSA, we prepared both poly(ADP-ribosyl)ated and unpoly(ADP-ribosyl)ated forms of the PARP-1 protein. Under control conditions (i.e. a nonenzymatic reaction without NAD + ), electrophoresed PARP-1 protein appears as a band of approximately 125 kD and is unpoly(ADP-ribosyl)ated (Fig. 3B, lane 1). After enzymatic activation in the presence of NAD + , electrophoresed PARP-1 proteins appear as both an unpoly(ADPribosyl)ated form (~125 kD) and a hyperpoly(ADP-ribosyl)ated form (>210 kD) (Fig. 3B, lane 2). When the enzymatic reaction was performed in the presence of 3-AB, both the 125 kD and 210 kD forms were present, although autopoly(ADP-ribosyl)ation of PARP-1 was inhibited (Fig. 3B, lane 3). To determine the physical interaction of PARP-1 with the mouse MOR promoter and verify its contribution to promoter activity, EMSAs were performed using recombinant PARP-1 and a regulatory sequence (NS;
In contrast, hyper-poly(ADP-ribosyl)ated PARP-1 did not bind the regulatory sequence
). When the enzymatic reaction was inhibited by 3-AB, binding of PARP-1 to NS was slightly increased, likely due to the decrease in the hyperpoly(ADP-ribosyl)ated form of PARP-1 (Fig. 3C, lane 4). A 100-fold molar excess of unlabelled NS oligonucleotide (Fig. 3C, lanes 5-7) completely inhibited complex formation. These results demonstrate that PARP-1 binds specifically to the MOR poly(C) sequence, while hyper-poly(ADP-ribosyl)ated PARP-1 does not. SDS-PAGE and western blots with anti-PARP-1 and anti-PAR detected the presence of both poly(ADP-ribosyl)ated PARP-1 and poly(ADP-ribosyl)ated proteins in affinity-purified samples (Fig. 3D). This suggested that PARP-1 might form part of a repressor complex with poly(ADP-ribosyl)ated proteins. To determine if poly(ADP-ribosyl)ated PARP-1 interacted physically with the poly(C) sequence of the mouse MOR proximal promoter, EMSAs were performed using purified poly(ADP-ribosyl)ated PARP-1 and the NS regulatory sequence from the MOR poly(C) sequence as a probe. The complex was present in the absence of antibody (Fig. 3E, asterisk). One microgram of anti-PARP-1 produced a minor supershifted band (arrow), while 2 µg of anti-PARP-1 produced a supershifted band (arrow) with concomitant reduction in the intensity of the complex band (asterisk). To determine if poly(ADP-ribosyl)ated PARP and poly(ADP-ribosyl)ated proteins bound DNA directly, we carried out gel shift assays using the anti-PAR (poly(ADP)-ribose) antibody. That antibody produce supershifted bands (arrow) containing poly(ADP-ribosyl)ated PARP-1 and poly(ADP-ribosyl)ated proteins
Defining the core PARP-1-binding motif of the poly(C) sequence
To determine the PARP-1 binding motif within the poly(C) sequence of the proximal promoter, EMSAs were carried out using recombinant PARP-1 and labelled NS sequence with sequences mutated as indicated (Fig. 4A; M1-M8) as competitors. Major complexes formed with labelled NS in the presence of M3, M5 and M7
and 10, respectively). Based on these observations, we determined that the poly(C) sequences 5´-CCCC-3´ (underlined in
ChIP allowed further confirmation in vivo of the specific binding of PARP-1 to the poly(C) sequence of the mouse MOR promoter (Fig. 4D). ChIP experiments using anti-PARP-1 in NS20Y cells showed that PARP-1 was densely localized to the mouse MOR proximal promoter. In contrast, chromatin from NS20Y cells immunoprecipitated with no antibody or anti-gal4 displayed little enrichment in the mouse MOR proximal promoter (Fig. 4D). These results indicate that PARP-1 binds to the poly(C) sequence of the mouse MOR promoter in vivo and that such binding is specific.
Fig. 1 Schematic representation of the mouse MOR gene and one-step purification of poly(C)-binding proteins using an affinity column and two-dimensional gel electrophoresis. (A) The poly(C) sequence of the mouse MOR proximal promoter. TIS, transcriptional initiation site. (B) Doublestranded oligonucleotides biotinylated on the 5´-terminal were used as affinity particles. For control experiments to eliminate non-specific binding of nuclear proteins, nuclear extracts were preincubated with 2500 pmoles of non-biotinylated doublestranded DNA (5ϫ competitor) prior to affinity purification. (C) Coomassie-stained images of poly(C)-binding proteins purified using an affinity column (Control and Sample) and separated by two-dimensional gel electrophoresis. Molecular weight markers are indicated on the left and pI values across the top. The arrows (a, b) indicate the 36-kD protein (␣-CP3) and the 124-kD band used for mass spectrometry identification, respectively.
PARP-1 represses mouse MOR proximal promoter activity through the PARP-1 binding motif
Fig. 3 Auto-poly(ADP-ribosyl)ation of PARP-1 in vitro and EMSA of poly(C)-binding sequence with recombinant PARP-1 and purified proteins. (A) The MOR poly(C) sequence (NS). (B) Auto-poly(ADP-ribosyl)ation of PARP-1 in vitro. Recombinant PARP-1 was incubated in the absence or presence of 10 mM 3-AB for 20 min. PARP-1 and poly(ADP-ribosyl)ated PARP-1 were detected using anti-PARP-1 and anti-poly(ADP-ribose) (anti-PAR).
-poly(C) sequence complex is indicated by an arrow. (D) Coomassie-stained gel of poly(C)-binding proteins purified from NS20Y nuclear extracts and western blot analysis of purified poly(C)-binding proteins probed with anti-PARP-1 and anti-PAR antibodies. Arrows indicate PARP-1, poly(ADP-ribosyl)ated PARP-1 and poly(ADP-ribosyl)ated proteins. (E) EMSA of purified poly(C)-binding proteins using anti-PARP and anti-PAR antibody. EMSAs were performed using Continued
Fig. 4 EMSA analysis of the PARP-1-binding motif using mutant oligonucleotide sequences and ChIP assay. (A) Representation of the double-stranded oligonucleotide sequence (NS) and mutant oligonucleotide sequences (M1-M8). (B) EMSAs were performed using unlabelled poly(C) sequence (NS; lane 2) or unlabelled poly(C) mutated sequences (M1-M8; lanes 3-10) as competitors for recombinant PARP-1 protein binding to a labelled poly(C) sequence. Lane 1: Negative control (no unlabelled poly(C) sequence). The PARP-1-poly(C) sequence complex is indicated by an arrow. (C) The PARP-1-binding motif of the poly(C) sequence (NS). (D) ChIP analysis by real-time qPCR for PARP-1 binding interaction with the MOR promoter poly(C) sequence. Interactions were examined by ChIP assay with anti-PARP antibody and nonspecific antibody (anti-gal4). Precipitated DNAs were amplified using mouse MOR and ␤-actin (negative control) primers.
unchanged (Fig. 6B) 
Effect of PARP-1 inhibition on mouse MOR gene expression
PARP-1 catalyzes the transfer of multiple ADP-ribose units to target nuclear proteins. 3-AB, a specific PARP-1 inhibitor, blocks poly(ADP-ribosyl)ation of PARP-1 and nuclear proteins. Mouse neuronal cells were treated with 2 mM 3-AB for 48 hrs in order to monitor the effects of PARP-1 inhibition on mouse MOR gene transcription. Treatment with 3-AB up-regulated mouse MOR mRNA levels nearly 2.5-fold over untreated cells (Fig. 7B). These data suggest that PARP-1-mediated poly(ADP-ribosyl)ation is essential for mouse MOR gene expression, and that PARP-1 plays an important role in the regulation of mouse MOR gene expression.
Discussion
Precise transcriptional regulation of opioid receptor genes in the brain is crucial for normal neuropharmacological function. Several classes of nuclear proteins are intricately involved in controlling
expression of these genes [1] . The 5´-flanking region of the mouse MOR has two promoters, distal and proximal, and the activities of each differ in the brain [14] . The proximal promoter is the major promoter of mouse MOR gene activity. It is regulated by various cis-elements and trans-factors, all of which are important for its activity [12] . Our earlier studies showed that mouse MOR transcription was regulated by a cis-acting element, a poly(C) sequence that was essential for the activity of the mouse MOR promoter through the binding of Sp1 and Sp3 [38] .
We have developed an efficient method to purify transcription factors [39] . This simple method has many advantages, including a smaller population of cells required for analysis, rapidity (<5 hrs), and a one-step process that eliminates the need for additional column chromatography. Additionally, this method is Fig. 5 PARP-1 (Fig. 7C) .
It has been reported that the poly(C) sequence of the mouse MOR promoter regulates the MOR gene through the binding of Sp1 and Sp3 [38] . However, in this study, the quantity of Sp1 or Sp3 binding to the poly(C) region was very small [39] 
